Cellcolabs vs OneThree Biotech
Cellcolabs vs OneThree Biotech, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellcolabs is on 55/100 and OneThree Biotech on 45/100.
Where each one leads
Cellcolabs
- our overall score: 55/100 against 45/100
- agent readiness: 40/100 against 22/100
- domain rating: 37/100 against 16/100
- funding raised: $15.5M against $2.8M
OneThree Biotech
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Cellcolabs | OneThree Biotech |
|---|---|---|
| What it is | AI-powered platform for personalized cell therapy development and manufacturing. | AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2021 | 2018 |
| Headquarters | Tel Aviv, Israel | New York City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellcolabs | OneThree Biotech |
|---|---|---|
| Employees | 79 | Not published |
| Total funding | $15.5M | $2.8M |
| Latest round | Not published | Seed |
| LinkedIn followers | 6,563 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellcolabs | OneThree Biotech |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 45/100 |
| Traction | Not published | 32/100 |
| Team | Not published | 70/100 |
| Search visibility | 2/100 | 14/100 |
| Quality | Not published | 50/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 37/100 | 16/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellcolabs | OneThree Biotech |
|---|---|---|
| CDN | Cloudflare | Not detected |
| Analytics | Google Tag Manager | Not detected |
Cellcolabs vs OneThree Biotech: common questions
Which is better, Cellcolabs or OneThree Biotech?
On our 0-100 score Cellcolabs rates higher (55/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Cellcolabs and OneThree Biotech compare on the numbers?
Cellcolabs leads on our overall score (55/100 against 45/100), agent readiness (40/100 against 22/100), domain rating (37/100 against 16/100), funding raised ($15.5M against $2.8M).
Read the full Cellcolabs review and pricing or the OneThree Biotech review and pricing. You can also browse other Cellcolabs alternatives we track.